Under Obamacare, Cost May Make The Best Drugs Unavailable

Monday, March 16, 2015 - 19:40 in Health & Medicine

New Hepatitis C drugs are terrific - but like every new drug they cost a lot of money to develop and took a lot of time to navigate the regulatory system and as a result they are not cheap. Most cost-benefit analyses have found that these new treatments save a lot more than treatment without them would cost, but with the Affordable Care Act already straining under gigantic expenses that politicians didn't consider when approving it, it may be more economical to force people to do without the best treatment in the short term and incur more costs later, after the economy has time to inflate away the ballooning costs of today. read more

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net